Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
life sciences
national blog main
akcea therapeutics
anylam pharmaceuticals
archive
biotech
boston blog main
boston top stories
cardiomyopathy
clinical trials
deals
drugs
food and drug administration
inotersen
medical
medical device
national top stories
neuropathy
new york
new york blog main
new york top stories
onpattro
patisiran
pfizer
pulmonary arterial hypertension
raleigh-durham blog main
san diego blog main
san diego top stories
san francisco
san francisco blog main
san francisco top stories
startups
steadymed
tafamidis
tegsedi
transthyretin amyloidosis
treprostinil
united therapeutics
What
disease
3
×
drug
3
×
rare
3
×
fda
genetic
therapy
administration
ago
akcea
alnylam
amyloidosis
approval
approved
approves
attr
available
battle
building
called
children
deal
debilitating
designed
developer
established
firm
food
gene
infants
issued
lung
medicines
momentum
oks
pah
patients
pfizer
rar
reaches
rivalry
Language
Current search:
disease
×
drug
×
rare
×
@slashgear.com
5 years ago
FDA approves $2.1m gene therapy for infants with rare genetic disease
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed
